Cannabigerovarin: Difference between revisions
CSV import |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 22: | Line 22: | ||
[[Category:Medicinal plants]] | [[Category:Medicinal plants]] | ||
{{Pharma-stub}} | {{Pharma-stub}} | ||
== Cannabigerovarin == | |||
<gallery> | |||
File:Cannabigerovarin.png | |||
File:CBGV_3D_BS.png | |||
</gallery> | |||
Latest revision as of 19:31, 16 March 2025
Cannabigerovarin (CBGV) is a natural phytocannabinoid found in the Cannabis plant. It is one of the many cannabinoids that contribute to the medicinal and psychoactive effects of cannabis. CBGV is a homolog of Cannabigerol (CBG), with the only difference being the presence of a propyl (three-carbon) side chain instead of a pentyl (five-carbon) side chain.
Chemistry[edit]
CBGV is a non-psychoactive cannabinoid, meaning it does not produce the "high" associated with cannabis use. It is a decarboxylated form of cannabigerovarinic acid (CBGVA), which is produced in the cannabis plant through the same biosynthetic pathway as other cannabinoids.
Pharmacology[edit]
The pharmacological effects of CBGV are still under investigation. However, preliminary research suggests that it may have potential therapeutic applications. Like other cannabinoids, CBGV interacts with the body's endocannabinoid system, which is involved in a variety of physiological processes.
Potential Therapeutic Uses[edit]
While research is still in its early stages, some studies suggest that CBGV may have potential therapeutic uses. These include anti-inflammatory effects, neuroprotective effects, and potential use in the treatment of certain types of cancer.
See Also[edit]
References[edit]
<references />
